Clinical Trial Update: Thiopurine EnhAnced Maintenance Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating thiopurine enhanced maintenance therapy in acute lymphoblastic leukemia and lymphoblastic lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Snippet

Sponsor: Kjeld Schmiegelow | Conditions: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 1, Phase 2 | Status: COMPLETED